The eye is a particularly sensitive organ, due to both the practical and emotional importance of sight to people’s wellbeing - and also its susceptibility to harm. Ophthalmology is therefore a strongly growing market sector for both the treatment of disease and maintenance of health.
The materials used in treating the eye play a very important role in such products, and this is an area of particular interest to Altrika Ltd; most notably the fields of topical drug delivery, cell delivery, self-irrigation and comfort.
Altrika Ltd has IP in the field of materials for stem cell delivery to the cornea for therapeutic benefit, with plans to enter clinical trials at Moorfields Eye Hospital, one of the leading eye treatment and research units in the world.